{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:26:51Z","timestamp":1793028411663,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bcp.2020.113947","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T10:55:41Z","timestamp":1585824941000},"page":"113947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases"],"prefix":"10.1016","volume":"177","author":[{"given":"Xia","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longmiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-nan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn","family":"Jitkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-xiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2020.113947_b0005","doi-asserted-by":"crossref","first-page":"e960759","DOI":"10.4161\/23723548.2014.960759","article-title":"Execution of RIPK3-regulated necrosis","volume":"1","author":"Cai","year":"2014","journal-title":"Mol. Cell. Oncol."},{"issue":"7534","key":"10.1016\/j.bcp.2020.113947_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2020.113947_b0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1310050","article-title":"Necroptosis","volume":"370","author":"Linkermann","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.113947_b0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.bcp.2020.113947_b0025","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2020.113947_b0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"issue":"5938","key":"10.1016\/j.bcp.2020.113947_b0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.1172308","article-title":"RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.bcp.2020.113947_b0040","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1073\/pnas.1200012109","article-title":"Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.113947_b0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2020.113947_b0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis","volume":"16","author":"Cai","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2020.113947_b0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.bcp.2020.113947_b0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cr.2013.171","article-title":"Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.113947_b0065","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.celrep.2014.04.026","article-title":"MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates","volume":"7","author":"Dondelinger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2020.113947_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","article-title":"Necroptosis: mechanisms and relevance to disease","volume":"12","author":"Galluzzi","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bcp.2020.113947_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104439","article-title":"Necroptosis signaling in liver diseases: an update","volume":"148","author":"Saeed","year":"2019","journal-title":"Pharmacol Res."},{"issue":"9","key":"10.1016\/j.bcp.2020.113947_b0080","doi-asserted-by":"crossref","DOI":"10.7326\/AITC201711070","article-title":"Acute kidney injury","volume":"167","author":"Levey","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcp.2020.113947_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.kint.2015.10.008","article-title":"Nonapoptotic cell death in acute kidney injury and transplantation","volume":"89","author":"Linkermann","year":"2016","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bcp.2020.113947_b0090","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000489940","article-title":"Necroptosis in acute kidney injury","volume":"139","author":"Anders","year":"2018","journal-title":"Nephron"},{"issue":"11","key":"10.1016\/j.bcp.2020.113947_b0095","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1681\/ASN.2014080741","article-title":"A role for tubular necroptosis in cisplatin-induced AKI","volume":"26","author":"Xu","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"29","key":"10.1016\/j.bcp.2020.113947_b0100","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.1073\/pnas.1305538110","article-title":"Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury","volume":"110","author":"Linkermann","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2020.113947_b0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2020.113947_b0110","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/bph.14653","article-title":"Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3","volume":"176","author":"Chen","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.113947_b0115","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/acs.jmedchem.7b01647","article-title":"Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4-c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships","volume":"61","author":"Yoshikawa","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113947_b0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.celrep.2013.08.044","article-title":"Structural insights into RIP3-mediated necroptotic signaling","volume":"5","author":"Xie","year":"2013","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.bcp.2020.113947_b0125","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1021\/jm400778d","article-title":"Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives","volume":"56","author":"Okaniwa","year":"2013","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2020.113947_b0130","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/leu.2016.287","article-title":"Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1\/RIP3 pathway","volume":"31","author":"Xin","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bcp.2020.113947_b0135","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/jm4017174","article-title":"Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search","volume":"57","author":"Zhuang","year":"2014","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2020.113947_b0140","doi-asserted-by":"crossref","first-page":"F1487","DOI":"10.1152\/ajprenal.00352.2012","article-title":"Mouse model of ischemic acute kidney injury: technical notes and tricks","volume":"303","author":"Wei","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2020.113947_b0145","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.4049\/jimmunol.0903356","article-title":"Differential roles of macrophages in diverse phases of skin repair","volume":"184","author":"Lucas","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2020.113947_b0150","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.celrep.2015.02.052","article-title":"Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1","volume":"10","author":"Najjar","year":"2015","journal-title":"Cell Rep."},{"issue":"15","key":"10.1016\/j.bcp.2020.113947_b0155","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1021\/jm901808w","article-title":"A type-II kinase inhibitor capable of inhibiting the T315I \u201cgatekeeper\u201d mutant of Bcr-Abl","volume":"53","author":"Choi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.113947_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.130","article-title":"A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis","volume":"6","author":"Fauster","year":"2015","journal-title":"Cell Death Dis."},{"issue":"51","key":"10.1016\/j.bcp.2020.113947_b0165","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.bcp.2020.113947_b0170","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/acs.jmedchem.9b00611","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2020.113947_b0175","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ymthe.2018.07.014","article-title":"Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice","volume":"26","author":"Li","year":"2018","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2020.113947_b0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/eji.1830111013","article-title":"F4\/80, a monoclonal antibody directed specifically against the mouse macrophage","volume":"11","author":"Austyn","year":"1981","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113947_b0185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.154.3.713","article-title":"Expression of the macrophage-specific antigen F4\/80 during differentiation of mouse bone marrow cells in culture","volume":"154","author":"Hirsch","year":"1981","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2020.113947_b0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1074\/jbc.271.1.486","article-title":"Molecular cloning of F4\/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family","volume":"271","author":"McKnight","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"11\u201312","key":"10.1016\/j.bcp.2020.113947_b0195","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00018-016-2198-x","article-title":"Generation of small molecules to interfere with regulated necrosis","volume":"73","author":"Degterev","year":"2016","journal-title":"Cell Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.bcp.2020.113947_b0200","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/jm400072p","article-title":"Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors","volume":"56","author":"Peng","year":"2013","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2020.113947_b0205","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2014-12-615906","article-title":"Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach","volume":"125","author":"Nonami","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2020.113947_b0210","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/acs.jmedchem.5b01618","volume":"59","author":"Liang","year":"2016","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2020.113947_b0215","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.bmcl.2015.07.006","article-title":"Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-Abl(T315I) mutant","volume":"25","author":"Lu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bcp.2020.113947_b0220","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1021\/acs.jmedchem.8b00882","article-title":"First SAR study for overriding NRAS mutant driven acute myeloid leukemia","volume":"61","author":"Cho","year":"2018","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2020.113947_b0225","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/acs.jmedchem.7b01449","article-title":"Tozasertib analogues as inhibitors of necroptotic cell death","volume":"61","author":"Hofmans","year":"2018","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2020.113947_b0230","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1093\/ndt\/gfs373","article-title":"Programmed necrosis in acute kidney injury","volume":"27","author":"Linkermann","year":"2012","journal-title":"Nephrol. Dial Transplant."},{"issue":"5","key":"10.1016\/j.bcp.2020.113947_b0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:13:51Z","timestamp":1757769231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220301751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":47,"alternative-id":["S0006295220301751"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113947","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113947"}}